In vitro activities of OPT-80 and comparator drugs against intestinal bacteria

被引:107
作者
Finegold, SA
Molitoris, D
Vaisanen, ML
Song, YL
Liu, CX
Bolaños, M
机构
[1] VA Greater Los Angeles Healthcare Syst, Med Serv, Los Angeles, CA USA
[2] VA Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA
[4] Univ Calif Los Angeles, Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90024 USA
关键词
D O I
10.1128/AAC.48.12.4898-4902.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The activities of OPT-80 against 453 intestinal bacteria were compared with those of seven other drugs. OPT-80 showed good activity against most clostridia, staphylococci, and enterococci, but streptococci, aerobic and facultative gram-negative rods, anaerobic gram-negative rods, and Clostridium ramosum were resistant. Poor activity against anaerobic gram-negative rods may maintain colonization resistance.
引用
收藏
页码:4898 / 4902
页数:5
相关论文
共 19 条
[1]   In vitro activity of OPT-80 against clostridium difcile [J].
Ackermann, G ;
Löffler, B ;
Adler, D ;
Rodloff, AC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :2280-2282
[2]  
[Anonymous], USE ANTIBIOTICS
[3]  
[Anonymous], HUMAN INTESTINAL MIC
[4]   ANTIBIOTIC-ASSOCIATED DIARRHEA [J].
BARTLETT, JG .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (04) :573-581
[5]   THE PHYLOGENY OF THE GENUS CLOSTRIDIUM - PROPOSAL OF 5 NEW GENERA AND 11 NEW SPECIES COMBINATIONS [J].
COLLINS, MD ;
LAWSON, PA ;
WILLEMS, A ;
CORDOBA, JJ ;
FERNANDEZGARAYZABAL, J ;
GARCIA, P ;
CAI, J ;
HIPPE, H ;
FARROW, JAE .
INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1994, 44 (04) :812-826
[6]   MECHANISMS AND IMPLICATIONS OF GLYCOPEPTIDE RESISTANCE IN ENTEROCOCCI [J].
DERLOT, E ;
COURVALIN, P .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S82-S85
[7]  
Fekety R, 1997, AM J GASTROENTEROL, V92, P739
[8]   Gastrointestinal microflora studies in late-onset autism [J].
Finegold, SM ;
Molitoris, D ;
Song, YL ;
Liu, CX ;
Vaisanen, ML ;
Bolte, E ;
McTeague, M ;
Sandler, R ;
Wexler, H ;
Marlowe, EM ;
Collins, MD ;
Lawson, PA ;
Summanen, P ;
Baysallar, M ;
Tomzynski, TJ ;
Read, E ;
Johnson, E ;
Rolfe, R ;
Nasir, P ;
Shah, H ;
Haake, DA ;
Manning, P ;
Kaul, A .
CLINICAL INFECTIOUS DISEASES, 2002, 35 :S6-S16
[9]   Quinupristin-dalfopristin resistance in gram-positive bacteria: Mechanism of resistance and epidemiology [J].
Hershberger, E ;
Donabedian, S ;
Konstantinou, K ;
Zervos, MJ .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (01) :92-98
[10]  
Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3